Real-world prognostic model for overall survival (OS) in patients (pts) with advanced urothelial cancer (aUC) treated with immune checkpoint inhibitors (ICI).

Ali Raza Khaki,Leonidas Nikolaos Diamantopoulos,Natalie J. Miller,Mehmet Asim Bilen,Victor Sacristan Santos,Rafael Morales-Barrera,Michael Edward Devitt,Ariel Ann Nelson,Evan Shreck,Hussein Assi,Roubini Zakopoulou,Alejo Rodriguez-Vida,Mark P. Lythgoe,Alexandra Drakaki,Monika Joshi,Pedro Isaacsson Velho,Lucía Alonso,Matthew D. Galsky,Guru Sonpavde,Petros Grivas

Real-world prognostic model for overall survival (OS) in patients (pts) with advanced urothelial cancer (aUC) treated with immune checkpoint inhibitors (ICI).

2020

447Background: While ICI prolong OS after platinum chemotherapy in aUC, outcomes vary based on clinical confounders. We aimed to develop a prognostic model in pts receiving ICI in a non-clinical tr...

Keywords:

Cancer
Oncology
Immune checkpoint
prognostic model
Pathology
Internal medicine
Medicine
Confounding
urothelial cancer
platinum chemotherapy
immune checkpoint inhibitors
overall survival
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations